This HTML5 document contains 81 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n10http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q90596048
rdf:type
wikibase:Item
schema:description
artículu científicu espublizáu en xunetu de 2018 2018 թվականի հուլիսի 11-ին հրատարակված գիտական հոդված scientific article published on 11 July 2018 im Juli 2018 veröffentlichter wissenschaftlicher Artikel wetenschappelijk artikel наукова стаття, опублікована в липні 2018
p:P577
wds:Q90596048-6E29C6A2-C728-4FBD-8B47-EA32B10BA7F9
wdt:P577
2018-07-11T00:00:00Z
p:P2093
wds:Q90596048-F9A9F722-7E40-4AD3-8C44-8D3158774D4E wds:Q90596048-EB0745A6-778B-4106-9CB6-A639EF7C92B7 wds:Q90596048-6DF1972F-DD0A-4A8C-AC10-671A0FBB3C0D wds:Q90596048-663B7B33-2289-4B71-84A2-77C3B9FB11BF wds:Q90596048-51F35001-4D30-448C-9F99-309922656A99 wds:Q90596048-26B2DF29-9065-47C6-9F6F-430AC573F421 wds:Q90596048-31576246-E045-4EC8-9112-B017223CA11E wds:Q90596048-159F5881-BE2C-444C-AF6A-55F1B0936121 wds:Q90596048-DA7EA46F-6D72-487A-A459-8B801052D26E wds:Q90596048-B52CCC59-46DB-452A-898F-AA63923C6070 wds:Q90596048-9D663EE1-ED7F-445F-8DFC-7C8FCFA7A52E
wdt:P2093
Emmanuelle Kuhn Frédéric Albarel Benjamin Bouillet Frédéric Illouz Bruno Verges Véronique Raverot Magali Haissaguerre Perrine Buffier Emilie Merlen Françoise Borson-Chazot Philippe Caron
rdfs:label
Endocrine side-effects of new anticancer therapies: Overall monitoring and conclusions Endocrine side-effects of new anticancer therapies: Overall monitoring and conclusions
skos:prefLabel
Endocrine side-effects of new anticancer therapies: Overall monitoring and conclusions Endocrine side-effects of new anticancer therapies: Overall monitoring and conclusions
schema:name
Endocrine side-effects of new anticancer therapies: Overall monitoring and conclusions Endocrine side-effects of new anticancer therapies: Overall monitoring and conclusions
p:P50
wds:Q90596048-ED9BFDC6-E49A-4E95-8631-B9F76F6BAA51 wds:Q90596048-33CC9986-66D0-442C-955F-51ADE0C05398 wds:Q90596048-141EC9F3-6BA9-4962-BF0D-DEFD353C8A25 wds:Q90596048-9A098DBA-38E0-456D-AF65-20BEFEBDA093 wds:Q90596048-AC420BC3-51B4-4A68-9DEE-8EED96BED01A wds:Q90596048-74903C56-2BEF-49FD-B863-EB9CF916349B wds:Q90596048-7B3E330B-6143-4B13-A7A9-DB17D3A6B5DE wds:Q90596048-81CDBC2B-EF03-4241-B752-9AD107B15A84 wds:Q90596048-93A26BFD-1603-4B6F-852E-6148E40D87D6 wds:Q90596048-D7E543F1-A77A-4686-B4BA-C3A97CFBE2C9 wds:Q90596048-DA0B9484-EE09-4D16-AD0E-5BB1E158C41A wds:Q90596048-E239F5D1-4F2B-4E43-B2EA-C6B6757C3461 wds:Q90596048-CB9190B3-3012-4D3B-99A8-A5AE537265AF
wdt:P50
wd:Q114429813 wd:Q40385751 wd:Q101135336 wd:Q90939729 wd:Q58441504 wd:Q72940457 wd:Q114429796 wd:Q89224277 wd:Q114429808 wd:Q95641675 wd:Q114779451 wd:Q57014579 wd:Q39453225
p:P1476
wds:Q90596048-5D7A4759-3AB3-435A-8A8B-1A479C3ABAF2
wdt:P1476
Endocrine side-effects of new anticancer therapies: Overall monitoring and conclusions
p:P304
wds:Q90596048-35945A86-A5F5-4D0F-8C86-F51DAA9111D2
wdt:P304
591-595
p:P31
wds:Q90596048-D4028163-5B38-495E-A5D1-709CC76DC61F
wdt:P31
wd:Q13442814
p:P698
wds:Q90596048-5CBD2CEF-C942-4C69-B9AC-838AC8587513
wdtn:P698
n8:30056975
wdt:P698
30056975
p:P1433
wds:Q90596048-3E9BD1BA-804C-49D3-9021-338BE5A23602
wdt:P1433
wd:Q15753551
p:P433
wds:Q90596048-D1992B7E-E747-4B77-8CF9-6C80E172EF49
p:P478
wds:Q90596048-3927F27C-5017-4444-81C6-48037C02B3CD
wdt:P433
5
wdt:P478
79
p:P356
wds:Q90596048-BFD69945-E304-4BCF-9F7F-DFB73B35380C
wdtn:P356
n10:J.ANDO.2018.07.005
wdt:P356
10.1016/J.ANDO.2018.07.005